30
Participants
Start Date
December 5, 2014
Primary Completion Date
May 9, 2016
Study Completion Date
September 26, 2016
IncobotulinumtoxinA
Active ingredient: Clostridium Botulinum neurotoxin Type A free from complexing proteins. Solution for injection prepared by reconstitution of powder with 0.9% Sodium Chloride (NaCl).
Placebo
Solution for injection prepared by reconstitution of powder with 0.9% Sodium Chloride (NaCl).
Merz Investigational Site #0010191, New York
Merz Investigational Site #0010317, Winnipeg
Merz Investigational Site #0010089, Halifax
Merz Investigational Site #0010078, Toronto
Merz Investigational Site #0010305/1, Toronto
Merz Investigational Site #0010305/2, Toronto
Lead Sponsor
Merz Pharmaceuticals GmbH
INDUSTRY